Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - STOCK-BASED COMPENSATION
Stock-based Compensation REGN - Regeneron Pharmaceuticals, Inc.
885 M
LAST VALUE
21.28%
2 YEAR CAGR
15.67%
5 YEAR CAGR
16.13%
10 YEAR CAGR